Selected research
Industry Research
Coronavirus Treatment Drugs Industry Research Report 2026
Market perspective
The global Coronavirus Treatment Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Coronavirus Treatment Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Coronavirus Treatment Drugs market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Coronavirus Treatment Drugs market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Coronavirus Treatment Drugs include Bharat Biotech International Limited, Cadila Healthcare Limited, CanSino Biologics, Celltrion Healthcare, Dr. Reddy's Laboratories, Gilead Sciences, Glenmark Pharmaceuticals Limited, Moderna and Novavax, Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Coronavirus Treatment Drugs market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Coronavirus Treatment Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Coronavirus Treatment Drugs Market by Company
Bharat Biotech International Limited
Cadila Healthcare Limited
CanSino Biologics
Celltrion Healthcare
Dr. Reddy's Laboratories
Gilead Sciences
Glenmark Pharmaceuticals Limited
Moderna
Novavax, Inc
Serum Institute of India
Sinovac Biotech
Sorrento Therapeutics
AstraZeneca Plc
GlaxoSmithKline Plc
Pfizer Inc
Eli Lilly and Company
Roche
Merck & Co., Inc
Johnson & Johnson
Coronavirus Treatment Drugs Segment by Type
Monoclonal Antibodies
Kinase Inhibitors
Anti-viral
Corticosteroids
Others
Coronavirus Treatment Drugs Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Coronavirus Treatment Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronavirus Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coronavirus Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronavirus Treatment Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Coronavirus Treatment Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal Antibodies
- Kinase Inhibitors
- Anti-viral
- Corticosteroids
- Others
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Bharat Biotech International Limited
- Cadila Healthcare Limited
- CanSino Biologics
- Celltrion Healthcare
- Dr. Reddy's Laboratories
- Gilead Sciences
- Glenmark Pharmaceuticals Limited
- Moderna
- Novavax, Inc
- Serum Institute of India
- Sinovac Biotech
- Sorrento Therapeutics
- AstraZeneca Plc
- GlaxoSmithKline Plc
- Pfizer Inc
- Eli Lilly and Company
- Roche
- Merck & Co., Inc
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Coronavirus Treatment Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Monoclonal Antibodies
- 2.2.3 Kinase Inhibitors
- 2.2.4 Anti-viral
- 2.2.5 Corticosteroids
- 2.2.6 Others
- 2.3 Coronavirus Treatment Drugs by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Retail Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Hospital Pharmacies
- 2.4 Assumptions and Limitations
3 Coronavirus Treatment Drugs Breakdown Data by Type
- 3.1 Global Coronavirus Treatment Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Coronavirus Treatment Drugs Forecasted Market Size by Type (2027-2032)
4 Coronavirus Treatment Drugs Breakdown Data by Application
- 4.1 Global Coronavirus Treatment Drugs Historic Market Size by Application (2021-2026)
- 4.2 Global Coronavirus Treatment Drugs Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Coronavirus Treatment Drugs Market Perspective (2021-2032)
- 5.2 Global Coronavirus Treatment Drugs Growth Trends by Region
- 5.2.1 Global Coronavirus Treatment Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Coronavirus Treatment Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Coronavirus Treatment Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Coronavirus Treatment Drugs Market Dynamics
- 5.3.1 Coronavirus Treatment Drugs Industry Trends
- 5.3.2 Coronavirus Treatment Drugs Market Drivers
- 5.3.3 Coronavirus Treatment Drugs Market Challenges
- 5.3.4 Coronavirus Treatment Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Coronavirus Treatment Drugs Players by Revenue
- 6.1.1 Global Top Coronavirus Treatment Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Coronavirus Treatment Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Coronavirus Treatment Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Coronavirus Treatment Drugs Head Office and Area Served
- 6.4 Global Coronavirus Treatment Drugs Players, Product Type & Application
- 6.5 Global Coronavirus Treatment Drugs Manufacturers Established Date
- 6.6 Global Coronavirus Treatment Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Coronavirus Treatment Drugs Market Size (2021-2032)
- 7.2 North America Coronavirus Treatment Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Coronavirus Treatment Drugs Market Size by Country (2021-2026)
- 7.4 North America Coronavirus Treatment Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Coronavirus Treatment Drugs Market Size (2021-2032)
- 8.2 Europe Coronavirus Treatment Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Coronavirus Treatment Drugs Market Size by Country (2021-2026)
- 8.4 Europe Coronavirus Treatment Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Coronavirus Treatment Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Coronavirus Treatment Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Coronavirus Treatment Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Coronavirus Treatment Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Coronavirus Treatment Drugs Market Size (2021-2032)
- 10.2 South America Coronavirus Treatment Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Coronavirus Treatment Drugs Market Size by Country (2021-2026)
- 10.4 South America Coronavirus Treatment Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Coronavirus Treatment Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Coronavirus Treatment Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Coronavirus Treatment Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bharat Biotech International Limited
- 12.1.1 Bharat Biotech International Limited Company Information
- 12.1.2 Bharat Biotech International Limited Business Overview
- 12.1.3 Bharat Biotech International Limited Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.1.4 Bharat Biotech International Limited Coronavirus Treatment Drugs Product Portfolio
- 12.1.5 Bharat Biotech International Limited Recent Developments
- 12.2 Cadila Healthcare Limited
- 12.2.1 Cadila Healthcare Limited Company Information
- 12.2.2 Cadila Healthcare Limited Business Overview
- 12.2.3 Cadila Healthcare Limited Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.2.4 Cadila Healthcare Limited Coronavirus Treatment Drugs Product Portfolio
- 12.2.5 Cadila Healthcare Limited Recent Developments
- 12.3 CanSino Biologics
- 12.3.1 CanSino Biologics Company Information
- 12.3.2 CanSino Biologics Business Overview
- 12.3.3 CanSino Biologics Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.3.4 CanSino Biologics Coronavirus Treatment Drugs Product Portfolio
- 12.3.5 CanSino Biologics Recent Developments
- 12.4 Celltrion Healthcare
- 12.4.1 Celltrion Healthcare Company Information
- 12.4.2 Celltrion Healthcare Business Overview
- 12.4.3 Celltrion Healthcare Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.4.4 Celltrion Healthcare Coronavirus Treatment Drugs Product Portfolio
- 12.4.5 Celltrion Healthcare Recent Developments
- 12.5 Dr. Reddy's Laboratories
- 12.5.1 Dr. Reddy's Laboratories Company Information
- 12.5.2 Dr. Reddy's Laboratories Business Overview
- 12.5.3 Dr. Reddy's Laboratories Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.5.4 Dr. Reddy's Laboratories Coronavirus Treatment Drugs Product Portfolio
- 12.5.5 Dr. Reddy's Laboratories Recent Developments
- 12.6 Gilead Sciences
- 12.6.1 Gilead Sciences Company Information
- 12.6.2 Gilead Sciences Business Overview
- 12.6.3 Gilead Sciences Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.6.4 Gilead Sciences Coronavirus Treatment Drugs Product Portfolio
- 12.6.5 Gilead Sciences Recent Developments
- 12.7 Glenmark Pharmaceuticals Limited
- 12.7.1 Glenmark Pharmaceuticals Limited Company Information
- 12.7.2 Glenmark Pharmaceuticals Limited Business Overview
- 12.7.3 Glenmark Pharmaceuticals Limited Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.7.4 Glenmark Pharmaceuticals Limited Coronavirus Treatment Drugs Product Portfolio
- 12.7.5 Glenmark Pharmaceuticals Limited Recent Developments
- 12.8 Moderna
- 12.8.1 Moderna Company Information
- 12.8.2 Moderna Business Overview
- 12.8.3 Moderna Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.8.4 Moderna Coronavirus Treatment Drugs Product Portfolio
- 12.8.5 Moderna Recent Developments
- 12.9 Novavax, Inc
- 12.9.1 Novavax, Inc Company Information
- 12.9.2 Novavax, Inc Business Overview
- 12.9.3 Novavax, Inc Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.9.4 Novavax, Inc Coronavirus Treatment Drugs Product Portfolio
- 12.9.5 Novavax, Inc Recent Developments
- 12.10 Serum Institute of India
- 12.10.1 Serum Institute of India Company Information
- 12.10.2 Serum Institute of India Business Overview
- 12.10.3 Serum Institute of India Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.10.4 Serum Institute of India Coronavirus Treatment Drugs Product Portfolio
- 12.10.5 Serum Institute of India Recent Developments
- 12.11 Sinovac Biotech
- 12.11.1 Sinovac Biotech Company Information
- 12.11.2 Sinovac Biotech Business Overview
- 12.11.3 Sinovac Biotech Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.11.4 Sinovac Biotech Coronavirus Treatment Drugs Product Portfolio
- 12.11.5 Sinovac Biotech Recent Developments
- 12.12 Sorrento Therapeutics
- 12.12.1 Sorrento Therapeutics Company Information
- 12.12.2 Sorrento Therapeutics Business Overview
- 12.12.3 Sorrento Therapeutics Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.12.4 Sorrento Therapeutics Coronavirus Treatment Drugs Product Portfolio
- 12.12.5 Sorrento Therapeutics Recent Developments
- 12.13 AstraZeneca Plc
- 12.13.1 AstraZeneca Plc Company Information
- 12.13.2 AstraZeneca Plc Business Overview
- 12.13.3 AstraZeneca Plc Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.13.4 AstraZeneca Plc Coronavirus Treatment Drugs Product Portfolio
- 12.13.5 AstraZeneca Plc Recent Developments
- 12.14 GlaxoSmithKline Plc
- 12.14.1 GlaxoSmithKline Plc Company Information
- 12.14.2 GlaxoSmithKline Plc Business Overview
- 12.14.3 GlaxoSmithKline Plc Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.14.4 GlaxoSmithKline Plc Coronavirus Treatment Drugs Product Portfolio
- 12.14.5 GlaxoSmithKline Plc Recent Developments
- 12.15 Pfizer Inc
- 12.15.1 Pfizer Inc Company Information
- 12.15.2 Pfizer Inc Business Overview
- 12.15.3 Pfizer Inc Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.15.4 Pfizer Inc Coronavirus Treatment Drugs Product Portfolio
- 12.15.5 Pfizer Inc Recent Developments
- 12.16 Eli Lilly and Company
- 12.16.1 Eli Lilly and Company Company Information
- 12.16.2 Eli Lilly and Company Business Overview
- 12.16.3 Eli Lilly and Company Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.16.4 Eli Lilly and Company Coronavirus Treatment Drugs Product Portfolio
- 12.16.5 Eli Lilly and Company Recent Developments
- 12.17 Roche
- 12.17.1 Roche Company Information
- 12.17.2 Roche Business Overview
- 12.17.3 Roche Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.17.4 Roche Coronavirus Treatment Drugs Product Portfolio
- 12.17.5 Roche Recent Developments
- 12.18 Merck & Co., Inc
- 12.18.1 Merck & Co., Inc Company Information
- 12.18.2 Merck & Co., Inc Business Overview
- 12.18.3 Merck & Co., Inc Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.18.4 Merck & Co., Inc Coronavirus Treatment Drugs Product Portfolio
- 12.18.5 Merck & Co., Inc Recent Developments
- 12.19 Johnson & Johnson
- 12.19.1 Johnson & Johnson Company Information
- 12.19.2 Johnson & Johnson Business Overview
- 12.19.3 Johnson & Johnson Revenue in Coronavirus Treatment Drugs Business (2021-2026)
- 12.19.4 Johnson & Johnson Coronavirus Treatment Drugs Product Portfolio
- 12.19.5 Johnson & Johnson Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst